ストックスクリーナーアプリを入手
417.89
0.41%
1.70
アフターアワーズ：
417.89
前日終値:
$416.19
開ける：
$422
24時間の取引高:
1.51M
Relative Volume:
0.88
時価総額：
$90.75B
収益：
$200.42B
当期純損益:
$5.24B
株価収益率:
17.78
EPS:
23.5042
ネットキャッシュフロー:
$6.45B
1週間 パフォーマンス:
+7.89%
1か月 パフォーマンス:
+7.42%
6か月 パフォーマンス:
+17.96%
1年 パフォーマンス:
+19.31%
1日の値動き範囲:
$414.68
$427.19
1週間の範囲:
$384.44
$427.19
52週間の値動き範囲:
$273.71
$427.19
Elevance Health Inc Stock (ELV) Company Profile
名前
Elevance Health Inc
セクター
電話
(800) 331-1476
住所
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV vs UNH, CVS, CI, HUM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
417.89 | 83.98B | 200.42B | 5.24B | 6.45B | 23.50 |
UNH
Unitedhealth Group Inc
|
425.36 | 377.45B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
104.72 | 131.99B | 407.94B | 2.90B | 7.39B | 2.2771 |
CI
Cigna Group
|
287.77 | 72.93B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
396.75 | 47.69B | 137.20B | 1.15B | 1.27B | 9.3439 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-08 | 開始されました | Evercore ISI | In-line |
| 2026-02-03 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-08 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-12-19 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2025-10-14 | 開始されました | Goldman | Neutral |
| 2025-07-21 | ダウングレード | Argus | Buy → Hold |
| 2025-07-18 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | アップグレード | Argus | Hold → Buy |
| 2025-01-22 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | ダウングレード | Argus | Buy → Hold |
| 2024-07-18 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-06-24 | 開始されました | Morgan Stanley | Overweight |
| 2024-05-30 | 開始されました | Robert W. Baird | Outperform |
| 2024-03-06 | 開始されました | Barclays | Overweight |
| 2023-07-12 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-03-28 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-08-22 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
すべてを表示
Elevance Health Inc (ELV) 最新ニュース
Elevance Health Inc. stock outperforms competitors on strong trading day - MSN
Elevance Health Inc (ELV) Stock Up 7.6% and Still Undervalued -- GF Score: 87/100 - GuruFocus
Elevance Health Rises as Medicare Sanctions Risk Appears to Ease - Quiver Quantitative
Elevance Health's Q2 2026 earnings: What to expect - MSN
Elevance Health highlights managed care strategy as investors track the stock - AD HOC NEWS
Elevance Health (ELV) Enhances Health OS to Automate Clinical Reviews and Reduce Provider Administrative Burdens - Yahoo Finance
Elevance Health, Inc. (ELV) latest stock news and headlines - Yahoo Finance Singapore
Global Strategist Portfolio's Elevance Health Inc(ELV) Holding History - GuruFocus
ELVElevance Health Inc Volatility & Greeks - Finviz
Medicare Advantage company pays $342M to government in midst of billing probe - Medical Marketing and Media
Is ELV Undervalued? DCF Says Worth $643 - GuruFocus
Elevance Health analysts hold a steady view, consensus frames the ELV shares - AD HOC NEWS
Elevance Health Inc. stock outperforms competitors despite losses on the day - MarketWatch
Elevance Health, Inc. (ELV) Latest Stock News & Headlines - Yahoo Finance
Elevance Health Foundation Awards $5.8 Million to Expand Behavioral Health Programs Nationwide - citybiz
Elevance Health (ELV) Fell Amid Healthcare Sector Downturn - Insider Monkey
Elevance Health Foundation Invests $5.8 Million to Strengthen Behavioral Health Access Nationwide - Business Wire
Elevance Health, Inc. (ELV) Stock Analysis: Discovering Growth Potential In Healthcare Plans - DirectorsTalk Interviews
Elevance Health, Inc.(NYSE: ELV) dropped from Russell 1000 Value-Defensive Index - marketscreener.com
Elevance Health, Inc.(NYSE: ELV) dropped from Russell 1000 Defensive Index - marketscreener.com
2 Reasons to Like ELV (and 1 Not So Much) - TradingView
The Anthem Enhanced Choice PPO from Elevance Health Inc.flexible coverage for self-employed Ameri - AD HOC NEWS
Elevance Health, Inc.(NYSE: ELV) added to Russell 1000 Dynamic Index - marketscreener.com
Elevance Health, Inc. (ELV) Investigation: Bronstein, Gewirtz & G - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Elevance Health, In - The National Law Review
Price to book forward of Elevance Health, Inc. – BX:A58 - TradingView
Price to earnings forward of Elevance Health, Inc. – NYSE:ELV - TradingView
Price to earnings forward of Elevance Health, Inc. – BMV:ELV - TradingView
Elevance tops $1B in housing investments: What's driving the strategy? - MSN
Elevance Health Prepares for Q2 2026 Earnings Amid Analyst Projections - sekbernews.id
Elevance Health opens the week with Carelon focus, shares steady - AD HOC NEWS
Price to sales forward of Elevance Health, Inc. – MUN:A58 - TradingView
Enterprise value to revenue forward of Elevance Health, Inc. – BMV:ELV - TradingView
Sydney Health app from Elevance Health Inc.AI coach, care navigation and rewards in one - Ad-hoc-news.de
Elevance Health Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Anthem to drop Meridian Health Services from Medicaid network - Inside INdiana Business
Can Carelon Drive Elevance Health's Future Earnings Growth? - The Globe and Mail
Elevance pays CMS $342M in midst of Medicare Advantage probe - Modern Healthcare
Elevance Health's Q2 2026 Earnings: What to Expect - Yahoo Finance
Elevance Health pairs CNSide oncology coverage with digital push, S&P 500 shares stay firm - Ad-hoc-news.de
Elevance Health, Inc. Actuals & Estimates (EUROTLX:4ANTM) - TradingView
Elevance Health, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.2 Sh - TradingView
CNSide signs coverage deal with Elevance Health for 45.4M - Investing.com UK
Elevance Health expands cancer test coverage, shares in S&P 500 spotlight - Ad-hoc-news.de
Plus Therapeutics wins Elevance Health coverage deal - MSN
ELV Forecast — Price Target — Prediction for 2027 - TradingView
Elevance Health (ELV) Launches Health OS To Make Care More Connected - Yahoo Finance
CNSide signs coverage deal with Elevance Health for 45.4M By Investing.com - Investing.com South Africa
New Elevance Health Public Policy Institute Study Examines Payment Disputes for Planned Procedures Under the No Surprises Act - Business Wire
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer - The Manila Times
Plus Therapeutics Subsidiary CNSide Diagnostics Signs National Coverage Agreement with Elevance Health for CNSide CSF Tumor Cell Enumeration Assay - Quiver Quantitative
Elevance Health Inc (ELV) 財務データ
収益
当期純利益
現金流量
EPS
3.86%
0.09%
大文字化:
|
ボリューム (24 時間):